Skip to content

Outcome After Revisions of Infected Knee Arthroplasties

Outcome After Revisions of Infected Knee Arthroplasties - a Prospective Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04427943
Acronym
RIKA
Enrollment
350
Registered
2020-06-11
Start date
2020-01-01
Completion date
2026-11-30
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic Knee Infection

Keywords

infection, knee arthroplasty, surgical treatment, patient reported outcome

Brief summary

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection.

Detailed description

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection. Most previous studies investigating outcomes after revisions of infected knee artrplasties are single-center studies and retrospective. The study group has previously investigated outcome of the surgical treatment of infected knee arthroplasties in Denmark based on nationwide data from Danish registries. These studies revealed that the risk of treatment failure causing re-revision or mortality was 30-40% in Denmark. Based on these findings, an ongoing randomized controlled trial one-stage versus two-stage revisions of the infected knee arthroplasty (ClinicalTrials.gov ID: NCT03435679) has been initiated by the study group in Febuary 2018. It has been possible to include 20% of the patients with surgically demanding periprosthetic knee infections from the including centres in this randomized trial due to in- and exclusions criteria. Hence, the investigators wish to include the remaining patients with periprosthetic knee joint infection in a prospective cohort study in order to obtain high quality prospective data on function, quality of life and complications after all types of surgical procedures performed due to periprosthetic knee joint infection. Based on these data it will be possible to evaluate the surgical treatment overall and it will be possible to evaluate whether the patients included in the randomized trial are representative. Study aim: To present patient reported outcome and postoperative complications after all types of surgical procedures performed due to periprosthetic knee infection. Furthermore, to analyze the role of potential risk factors (patient comorbidity, microbiological diagnosis, surgical intervention, antibiotic treatment, duration of symptoms) on outcome of the patients.

Interventions

The intervention is the planned revision surgery according to local guidelines.

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Clinical signs of periprosthetic knee joint infection and indication for revision surgery * Speak and understand Danish and have given informed consent

Exclusion criteria

* Participation in one-stage versus two-stage revisions of the infected knee arthroplasty

Design outcomes

Primary

MeasureTime frameDescription
Change in Oxford Knee Score (Area Under Curve (AUC) from preoperatively to 12 months postoperatively)Measured preoperatively 6 weeks, 3, 6, 9, 12 months postoperativelyChange in Oxford Knee Score from preoperatively to 12 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.

Secondary

MeasureTime frameDescription
Change in Oxford Knee Score (Area Under Curve, AUC from preop. to 12 months postop.)Time Frame: Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperativelyChange in Oxford Knee Score from preoperatively to 24 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.
Change in EuroQol five-dimensional descriptive system (EQ-5D-5L) from preop to 24 months postop.Measured preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.Quality of life questionnaire
Number of participants re-revised (re-revision rate)2 year postoperativelyNumber of patients re-revised due to infection and other causes within 2 years postoperatively.
Number of participants dying (mortality rate)2 years postoperativelyNumber of participants dying within 2 years posoperatively
Number of participants readmitted (readmission rate)90 days postoperativelyNumber of participant readmitted within 90 days postoperatively

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026